Get startedLog in
    Picture of Evotec SE logo

    EVT — Evotec SE News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Evotec to receive $100 mln as Gilead acquires Tubulis

    Picture of Evotec SE logoEvotec SE
    07/04/2026 14:02
    April 7 (Reuters) - German biotech company Evotec EVTG.DE is to receive around $100 million upfront following the closing of the sale of private Germany-based Tubulis to Gilead, the company said on Tuesday.

Gilead GILD.O said it would acquire Tubulis for up to $5 billion, as the U.S. drugmaker looks to boost its pipeline with a lucrative class of experimental cancer drugs.

 (Reporting by Tristan Veyet in Gdansk, editing by Miranda Murray)

 ((Tristan.veyet@thomsonreuters.com;))

    Recent news on Evotec SE

    See all news